SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer
SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer Summary This Nature paper identifies SLAMF6 as an inhibitory, drug-targetable receptor that dampens CD8+ T cell responses in cancer.…
